rss
Br J Ophthalmol 2003;87:305-306 doi:10.1136/bjo.87.3.305
  • Original Article
    • Clinical science

Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion

  1. C Hvarfner1,
  2. A Hillarp2,
  3. J Larsson1
  1. 1Department of Ophthalmology, Lund University Hospital, Sweden
  2. 2Department of Clinical Chemistry, Malmö University Hospital, 211 85 Malmö, Sweden
  1. Correspondence to: Charlotte Hvarfner, Department of Ophthalmology, Lund University Hospital, 211 85 Lund, Sweden; charlotte.hvarfner{at}oft.lu.se
  • Accepted 4 September 2002

Abstract

Aims: To investigate if the presence of factor V Leiden has an influence on the prognosis in central retinal vein occlusion (CRVO).

Methods: 166 patients with CRVO were studied retrospectively. They were tested for factor V Leiden using DNA analysis. The presence of the mutation was studied in correlation with the development of neovascular complications 1 year after the thrombotic event.

Results: 56 of 166 patients (34%) developed neovascular complications after 1 year. In the patients who had the studied mutation 11 of 20 (55%) had developed neovascular complications after 1 year, compared to 45 of 146 patients (31%) in the group without factor V Leiden (p=0.04).

Conclusion: The presence of factor V Leiden seems to enhance the risk of developing neovascular complications in CRVO.

Footnotes

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.